TUDOR INVESTMENT CORP ET AL - AIMMUNE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$34,088,000
+5571.9%
989,506
+3345.1%
1.48%
+6961.9%
Q3 2019$601,000
+85.5%
28,722
+235.7%
0.02%
+162.5%
Q4 2017$324,000
-12.2%
8,555
-42.5%
0.01%
-11.1%
Q3 2017$369,000
+200.0%
14,885
+30.6%
0.01%
+200.0%
Q2 2016$123,00011,4000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders